{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T10:34:37Z","timestamp":1763116477019},"reference-count":18,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["SEMERGEN - Medicina de Familia"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.semerg.2015.06.008","type":"journal-article","created":{"date-parts":[[2015,9,24]],"date-time":"2015-09-24T15:54:31Z","timestamp":1443110071000},"page":"293-297","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antiagregaci\u00f3n plaquetaria dual y nivel de hemoglobina: un estudio observacional"],"prefix":"10.1016","volume":"42","author":[{"given":"M.P.","family":"Quinteiro-Alonso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gonz\u00e1lez-Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Barreales-Card\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.J.","family":"D\u00edaz-Gr\u00e1valos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semerg.2015.06.008_bib0095","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1157\/13099977","article-title":"Asociaci\u00f3n de antiagregantes, \u00bfcu\u00e1ndo y c\u00f3mo?","volume":"128","author":"L\u00f3pez Menchaca","year":"2007","journal-title":"Med Clin (Barc)."},{"key":"10.1016\/j.semerg.2015.06.008_bib0100","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med."},{"key":"10.1016\/j.semerg.2015.06.008_bib0105","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa050522","article-title":"Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation","volume":"352","author":"Sabatine","year":"2005","journal-title":"N Engl J Med."},{"key":"10.1016\/j.semerg.2015.06.008_bib0110","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention. A randomized controlled trial","volume":"288","author":"Steinbuhl","year":"2002","journal-title":"JAMA."},{"key":"10.1016\/j.semerg.2015.06.008_bib0115","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): Randomised, double-blind, placebo-controlled trial","volume":"364","author":"Diener","year":"2004","journal-title":"Lancet."},{"key":"10.1016\/j.semerg.2015.06.008_bib0120","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1056\/NEJMoa1204133","article-title":"Effects of clopidogrel added to aspirin in patients with recent lacunar stroke","volume":"367","author":"Benavente","year":"2012","journal-title":"N Engl J Med."},{"key":"10.1016\/j.semerg.2015.06.008_bib0125","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ahj.2010.05.017","article-title":"Rationale and design of a randomized, double-blind trial comparing the effects of a 3-month clopidogrel-aspirin regimen versus aspirin alone for the treatment of high-risk patients with acute nondisabling cerebrovascular event","volume":"160","author":"Wang","year":"2010","journal-title":"Am Heart J."},{"key":"10.1016\/j.semerg.2015.06.008_bib0130","unstructured":"Organizaci\u00f3n Mundial de la Salud. Concentraciones de hemoglobina para diagnosticar la anemia y evaluar su gravedad. WHO\/NMH\/NHD\/MNM\/11.1. Ginebra: OMS; 2011 [consultado 20 Abr 2014]. Disponible en: http:\/\/www.who.int\/vmnis\/indicators\/haemoglobin_es.pdf"},{"key":"10.1016\/j.semerg.2015.06.008_bib0135","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.amjcard.2007.11.057","article-title":"Meta-analysis of the efficacy and safety of clopidogrel plus aspirin as compared to antiplatelet monotherapy for the prevention of vascular events","volume":"101","author":"Bowry","year":"2008","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.semerg.2015.06.008_bib0140","doi-asserted-by":"crossref","first-page":"463","DOI":"10.7326\/0003-4819-159-7-201310010-00006","article-title":"Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: A systematic review and meta-analysis","volume":"159","author":"Lee","year":"2013","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.semerg.2015.06.008_bib0145","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ahj.2008.09.011","article-title":"Bleeding risk associated with 1 year of dual antiplatelet therapy alter percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial","volume":"157","author":"Aronow","year":"2009","journal-title":"Am Heart J."},{"key":"10.1016\/j.semerg.2015.06.008_bib0150","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1161\/CIRCULATIONAHA.110.973008","article-title":"Risk of upper gastrointestinal bleeding with low-dose acetylsalicylic acid alone and in combination with clopidogrel and other medications","volume":"123","author":"Garc\u00eda Rodr\u00edguez","year":"2011","journal-title":"Circulation."},{"key":"10.1016\/j.semerg.2015.06.008_bib0155","doi-asserted-by":"crossref","first-page":"e65754","DOI":"10.1371\/journal.pone.0065754","article-title":"The efficacy and adverse reaction of bleeding of clopidogrel plus aspirin as compared to aspirin alone after stroke or TIA: A systematic review","volume":"8","author":"Huang","year":"2013","journal-title":"PLoS One."},{"key":"10.1016\/j.semerg.2015.06.008_bib0160","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1161\/CIRCULATIONAHA.109.895342","volume":"121","author":"Berger","year":"2010","journal-title":"Circulation."},{"key":"10.1016\/j.semerg.2015.06.008_bib0165","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N Engl J Med."},{"key":"10.1016\/j.semerg.2015.06.008_bib0170","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1503\/cmaj.070186","article-title":"Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding","volume":"177","author":"Delaney","year":"2007","journal-title":"CMAJ."},{"key":"10.1016\/j.semerg.2015.06.008_bib0175","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0140-6736(00)04015-0","article-title":"Fatal aplastic anaemia associated with clopidogrel","volume":"357","author":"Trivier","year":"2001","journal-title":"Lancet."},{"key":"10.1016\/j.semerg.2015.06.008_bib0180","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.amjcard.2011.11.049","article-title":"Impact of anemia on platelet response to clopidogrel in patients undergoing percutaneous coronary stenting","volume":"109","author":"Toma","year":"2012","journal-title":"Am J Cardiol."}],"container-title":["SEMERGEN - Medicina de Familia"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359315002506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359315002506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T07:28:10Z","timestamp":1537342090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1138359315002506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S1138359315002506"],"URL":"https:\/\/doi.org\/10.1016\/j.semerg.2015.06.008","relation":{},"ISSN":["1138-3593"],"issn-type":[{"value":"1138-3593","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiagregaci\u00f3n plaquetaria dual y nivel de hemoglobina: un estudio observacional","name":"articletitle","label":"Article Title"},{"value":"SEMERGEN - Medicina de Familia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semerg.2015.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2014 Sociedad Espa\u00f1ola de M\u00e9dicos de Atenci\u00f3n Primaria (SEMERGEN). Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}